[Form 4] Cel-Sci Corporation Insider Trading Activity

Rhea-AI Filing Summary

Cel-Sci Corp. (CVM) Form 4 filing discloses that Chief Executive Officer and Director Geert R. Kersten purchased 2,292 shares of common stock on 06/30/2025 at a price of $2.29 per share. Following the transaction, Kersten directly holds 43,638 shares. No derivative security activity was reported. The filing was signed on 07/01/2025 and represents a single-person submission under Section 16 reporting requirements.

Positive

• CEO insider purchase: Direct acquisition of 2,292 shares may signal management confidence and improve shareholder alignment.

Negative

• Immaterial size: Transaction value is low (≈$5,250), limiting its significance to overall ownership or company fundamentals.

Insights

Securities Analyst

TL;DR: Small CEO buy is directionally positive but immaterial to valuation; signals modest confidence.

Kersten’s open-market purchase demonstrates personal commitment, yet the dollar value (≈$5,250) represents a negligible fraction of market cap and his existing stake. Such routine acquisitions rarely shift financial outlook or liquidity, but they may help sentiment by aligning insider and shareholder interests. Absence of derivative activity suggests straightforward cash purchase rather than option exercise.

Corporate Governance Expert

TL;DR: Insider buying improves alignment; transaction size limits impact.

Directors buying shares is generally viewed favorably under governance best practices. However, with only 2,292 shares added, Kersten’s incremental ownership increase is modest. Investors should consider longer-term insider trading patterns and forthcoming operational milestones before drawing strong conclusions.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KERSTEN GEERT R

(Last) (First) (Middle)

8229 BOONE BLVD

STE 802

(Street)

VIENNA VA 22182

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CEL SCI CORP [ CVM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/30/2025		A		2,292	A	$2.29	43,638	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	Geert Kersten	07/01/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many CVM shares did CEO Geert Kersten buy?

He purchased 2,292 common shares.

At what price were the CVM shares acquired?

The acquisition price was $2.29 per share.

What is Geert Kersten’s total direct ownership after the trade?

His direct holdings increased to 43,638 shares.

Were any derivative securities involved in this Form 4?

No; the filing shows no options, warrants, or other derivatives.

When was the Form 4 signed and filed?

The document was signed on 07/01/2025.